Pfizer-New Delhi: to Try to do a large part of the year of young people, the global vaccine manufacturer, Pfizer, has announced that it will begin testing a COVID-19 vaccine in a group of children as young as 12. Pfizer is going to start testing with a sample of low-dose, needles, also in the early stages of testing. The vaccine is manufactured by Pfizer and its German partner, BioNTech is currently available in the countries such as the united states, Europe, and Canada, for the young people between the ages of 12 and 18 years of age. They’re also an adult dose, i.e. 30 micrograms (mcg).
Pfizer is going to start to try 4,500 children in more than 90 clinical centers in the united states, Finland, Poland, and Spain, the company said in a statement. Depending on the security of the transport and of the immune system, the call of the 144 children in a phase I study with a double-dose, needle-medication, the manufacturer will be expanding the testing of children aged from 5 to 11 years of age, with a 10-microg vaccine, injection, and (3 micrograms (mcg) for the 6-month to 5-year-old age group.
The details of the trial of a vaccine for children as young as 12 can be achieved, and as early as September, the company said, adding that it expects regulators to approve its early use of these months of the year. For children aged 2 to 5 years of age, these data are expected soon thereafter.
According to the U.s. Centers for Disease Control and Prevention, nearly 7 million young people who have already been at least one dose of the vaccine in the united states.
India is also in talks with Pfizer in order to start the production of its COVID-19 vaccine, in order to begin the vaccination of children over the age of 12 years old;-. The vaccination of children is an essential step in order to achieve “herd immunity” against the deadly virus.
Last week, the Uk’s drug regulator, which has expanded Pfizer and BioNTech coronavirus vaccine to children aged 12 to 15, said it was a “safe and effective” at this age, and the benefits outweigh the potential risks.